{"data":{"type":"feed_item","id":389530,"entity_id":"wefunder:feed_item:389530","attributes":{"canonical_url":"https://wefunder.com/feed/389530","retrieval_urls":{"canonical":"https://wefunder.com/feed/389530","json":"https://wefunder.com/feed/389530.json","markdown":"https://wefunder.com/feed/389530.md","ai_json":"https://wefunder.com/feed/389530.ai.json","ai_text":"https://wefunder.com/feed/389530.ai.txt","changelog_json":"https://wefunder.com/feed/389530.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-09-17T22:36:43.662Z","generated_at":"2026-09-22T00:01:31Z","profile_visibility":"public","feed_item":{"id":389530,"entity_id":"wefunder:feed_item:389530","type":"FeedItem::Update","title":"An exciting regulatory update 🙌 | Sempresto","content_plain":"Sempresto reached an important regulatory milestone this month: we received written feedback from the FDA following our Type B pre-IND meeting.","published_at":"2026-09-17T20:19:17.419Z","updated_at":"2026-09-17T22:36:43.662Z","canonical_url":"https://wefunder.com/feed/389530","author":{"name":"Elizabeth Reczek","profile_url":"https://wefunder.com/elizabethreczek"},"subject":{"name":"Sempresto","profile_url":"https://wefunder.com/sempresto"}},"provenance":{"source":"wefunder_public_feed_item","last_verified_at":"2026-09-17T22:36:43Z","claims":{"title":{"source":"feed_item.title","last_verified_at":"2026-09-17T22:36:43Z","as_of":"2026-09-17T22:36:43Z","confidence":"high"},"published_at":{"source":"feed_item.published_at","last_verified_at":"2026-09-17T22:36:43Z","as_of":"2026-09-17T20:19:17Z","confidence":"high"}}}}}}